ATC Group: N02AA08 Dihydrocodeine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N02AA08 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N02 Analgesics
3 N02A Opioids
4 N02AA Natural opium alkaloids
5 N02AA08 Dihydrocodeine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.15 g

Active ingredients in N02AA08

Active Ingredient Description
Dihydrocodeine

Dihydrocodeine is a semisynthetic narcotic analgesic with a potency between morphine and codeine. It is also a centrally-acting anti-tussive. Dihydrocodeine works on the cough centre to lessen the incidence and intensity of coughing fits.

Related product monographs

Title Information Source Document Type  
PARACODIN Oral drops, solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
PARACODIN Syrup Health Products Regulatory Authority (IE) MPI, EU: SmPC
PARACODIN Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicines in this ATC group

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.